The value of tumor markers in pulmonary tuberculosis;Apport des marqueurs tumoraux dans la tuberculose pulmonaire

Tunisie Medicale

Volumn 87, Issue 5, 2009, Pages 330-333

  Raci, H ^a,b   Saad, S ^a,b   Rouhou, S Cheikh ^a,b   Chaouch, N ^a,b   Zarrouk, M ^a,b   Yaalaoui, S ^a   Chabbou, Abdellatif ^a,b  

^a ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

CA 125; NSE; Pulmonary tuberculosis; Tumor markers

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; ETHAMBUTOL; ISONIAZID; NEURON SPECIFIC ENOLASE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT; TUMOR MARKER;

ADULT; AGE; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEVER; HEMOPTYSIS; HUMAN; LUNG CANCER; LUNG TUBERCULOSIS; MALE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SMOKING; SYMPTOMATOLOGY; THORAX PAIN; THORAX RADIOGRAPHY; ADOLESCENT; AGED; BLOOD; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 73949141889     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Menard O, Dousset B, Jacob C. Le dosage des marqueurs Tumoraux dans le liquide de lavage broncho-alvéolaire en cancérologie broncho-pulmonaire. Immunoanal Biol Spec 1992; 35:23-27.
2. Société de Pneumologie de Langue Française. Recommandations concernant l'utilisation des marqueurs tumoraux dans la prise en charge des cancers bronchiques primitifs. Cancérologie Aujourd'hui 1997; 6:293-307.
3. Porcel JM, Vives M, Esquerda A, Salud A, Perez B, Panadero FR. Use of a Panel of Tumor Markers (Carcinoembryonic Antigen, Cancer Antigen 125, Carbohydrate Antigen 15-3, and Cytokeratin 19 Fragments) in Pleural Fluid for the Differential Diagnosis of Benign and Malignant Effusions. Chest 2004; 126:1757-1763.
4. Ghayumi SM, Mehrabi S, Doroudchi M, Ghaderi A. Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients. Pathol Oncol Res 2005; 11:236-241.
5. Villena V, López-Encuentra A, Echave-Sustaeta J, Martín-Escribano P, Ortuño-de-Solo B, Estenoz-Alfaro J. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients. Cancer 1996; 78:736-740.
6. Pichon MF. Rôle des marqueurs tumoraux dans le comportement biologique de tumeurs solides. Imm Biol Spec 2004; 19:241-249.
7. Pichon MF, Eche N, Basuyau JP, Riedinger JM. Surveillance biologique en cancérologie : problèmes rencontrés avec les dosages de marqueurs tumoraux. Imm Biol Spec 2007; 22:34-40.
8. Thakur V, Mukherjee U, Kumar K. Elevated serum cancer antigen 125 levels in advanced abdominal tuberculosis. Med Oncol 2001; 18:289-291.
9. Çorapçioglu F, Güvenç BH, Sarper N, Aydogan A, Akansel G, Arisoy ES. Peritoneal tuberculosis with elevated serum CA 125 level mimicking advanced ovarian carcinoma in an adolescent. Turk J Pediatr 2006 ; 48:69-72.
10. Yilmaz A, Ece F, Bayramgürler B, Akkaya E, Baran R. The value of Ca 125 in the evaluation of tuberculosis activity. Respir Med 2001; 95:666-669.